Yoğun Bakımda Çoklu İlaca Dirençli Tüberküloz Hastası
Özet
Referanslar
World Health Organization (WHO). Global tuberculosis report 2023. World Heal Organ 2023; Available from: https://iris.who.int/.
Meya DB, McAdam KPWJ. The TB pandemic: an old problem seeking new solutions. J Intern Med. 2007;261(4):309–29
Pablos-Méndez A, Raviglione MC, Laszlo A, Binkin N, Rieder HL, Bustreo F, et al. Global Surveillance for Antituberculosis-Drug Resistance, 1994–1997. N Engl J Med. 1998;338(23):1641–9.
Flament-Saillour M, Robert J, Jarlier V, Grosset J. Outcome of Multi-drug-resistant Tuberculosis in France. Am J Respir Crit Care Med. 2012;160(2):587–93.
Drobniewski F, Eltringham I, Graham C, Magee JG, Smith EG, Watt B. A national study of clinical and laboratory factors affecting the survival of patients with multiple drug resistant tuberculosis in the UK. Thorax. 2002;57(9):810–6.
Lalloo UG, Naidoo R, Ambaram A. Recent advances in the medical and surgical treatment of multi-drug resistant tuberculosis. Curr Opin Pulm Med. 2006;12(3):179–85.
Kang YA, Choi YJ, Cho YJ, Lee SM, Yoo CG, Kim YW, et al. Cost of treatment for multidrug-resistant tuberculosis in South Korea. Respirology [Internet]. 2006 Nov 1 [cited 2024 Jun 4];11(6):793–8. Available from: https://onlinelibrary.wiley.com/doi/full/10.1111/j.1440-1843.2006.00948.x
Resch SC, Salomon JA, Murray M, Weinstein MC. Cost-Effectiveness of Treating Multidrug-Resistant Tuberculosis. PLOS Med. 2006;3(7):e241.
Rattan A, Kalia A, Ahmad N. Multidrug-resistant Mycobacterium tuberculosis: molecular perspectives. Emerg Infect Dis. 1998;4(2):195.
Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect Dis. 2003;3(1):13–21.
Ec B, Rms M, Mfm M, Cl C, Jb B, Jln R, et al. Fatores associados aos tratamentos inadequados em grupo de portadores de tuberculose multirresistente. J Pneumol. 2003;29(6):350–7.
World Health Organization (WHO). Guidelines for the programmatic management of drug-resistance tuberculosis. Geneva; 2011.
Yew WW, Chan CK, Chau CH, Tam CM, Leung CC, Wong PC, et al. Outcomes of Patients With Multidrug-Resistant Pulmonary Tuberculosis Treated With Ofloxacin/Levofloxacin-Containing Regimens. Chest. 2000;117(3):744–51.
World Health Organization (WHO). WHO consolidated guidelines on tuberculosis Module 4: Treatment Drug-resistant tuberculosis treatment 2022 update. 2022;
Chan ED, Laurel V, Strand MJ, Chan JF, Huynh MLN, Goble M, et al. Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis. Am J Resp Crit Care Med 2004;169(10):1103–9.
Kaplan G, Post FA, Moreira AL, Wainwright H, Kreiswirth BN, Tanverdi M, et al. Mycobacterium tuberculosis Growth at the Cavity Surface: A Microenvironment with Failed Immunity. Infect Immun]. 2003;71(12):7099–108.
Sung SW, Kang CH, Kim YT, Han SK, Shim YS, Kim JH. Surgery increased the chance of cure in multi-drug resistant pulmonary tuberculosis. Eur J Cardio-Thoracic Surg 1999;16(2):187–93.
Furák J, Troján I, Szöke T, Tiszlavicz L, Morvay Z, Csada E, et al. Surgical intervention for pulmonary tuberculosis: Analysis of indications and perioperative data relating to diagnostic and therapeutic resections. Eur J Cardio-thoracic Surg 2001;20(4):722–7.
Freixinet J, Rivas JJ, Felipe Rodríguez De Castro, Jose Antonio Caminero PR, Serra M, Mercedes de La Torre NS, Canalis E. Medical Science Monitor | Role of surgery in pulmonary tuberculosis. - Article abstract #4812. Med Sci Monit 2002;8(12):4812.
Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N. Resectional surgery combined with chemotherapy remains the treatment of choice for multidrug-resistant tuberculosis. J Thorac Cardiovasc Surg. 2004;128(4):523–8.
Takeda SI, Maeda H, Hayakawa M, Sawabata N, Maekura R. Current Surgical Intervention for Pulmonary Tuberculosis. Ann Thorac Surg. 2005;79(3):959–63.
Joseph P, Severe P, Ferdinand S, Kye SG, Sola C, Haas DW, et al. Multidrug-resistant tuberculosis at an HIV testing center in Haiti. AIDS 2006;20(3):415–8.
